PillRx only · Film · Buccal
Buprenorphine And Naloxone
Buprenorphine Hydrochloride + Naloxone Hydrochloride
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.537
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
5
Active US suppliers
48%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
560K
Rx · 2026 Q1
23.5M
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Redpharm Drug | unknown | 7 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Aveva Drug Delivery Systems Inc. | unknown | 4 | SUPPLYING |
| Alvogen Inc. | unknown | 4 | SUPPLYING |
| Ingenus Pharmaceuticals, LLC | unknown | 4 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 26, 2021RECALLRecall (Class II): Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alv…
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low) — Recalling firm: Alvogen, Inc — USA nationwide.